吉林省中医药管理局中西药药效协同作用重点研究室负责人，第一作者/通讯作者发表SCI及中华期刊论文50余篇；以第一完成人完成发明专利3项；第一负责人承担国家自然科学基金项目等课题20项。 代表性成果： 1.Song YQ(2023). Potential role of irisin in digestive system diseases. Biomed Pharmacother. 2023 Oct;166:115347.(一区，IF=7.5) 2.Song YQ(2022). Egg white protein hydrolysate ameliorated sepsis-induced inflammatory injuries in kidney and liver based on metabolomics analysis. Biomed Pharmacother. 2022 Sep;153:113442.(一区，IF=7.5） 3.Song YQ(2021). Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study. Biochem Pharmacol. 2021 Jan;183:114299. (二区，IF=5.8) 4.Song YQ(2021). Changes of Lipopolysaccharide-Induced Acute Kidney and Liver Injuries in Rats Based on Metabolomics Analysis. J Inflamm Res. 2021 May 6;14:1807-1825.(二区，IF=4.5) 5.Song YQ(2021). Huaiqihuang (HQH) granule alleviates cyclophosphamide-induced nephrotoxicity via suppressing the MAPK/NF-κB pathway and NLRP3 inflammasome activation. Pharm Biol. 2021 Dec;59(1):1425-1431. (二区，IF=3.8) 6.Song YQ(2020). 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Biomed Pharmacother. 2020 Apr;124:109891.(一区，IF=7.5) 7.Song YQ(2020). Omeprazole attenuates cisplatin-induced kidney injury through suppression of the TLR4/NF-κB/NLRP3 signaling pathway. Toxicology. 2020 Jul;440:152487.(二区，IF=4.5) 8.Song YQ(2020). Quercetin attenuates NLRP3 inflammasome activation and apoptosis to protect INH-induced liver injury via regulating SIRT1 pathway. Int Immunopharmacol. 2020 Aug;85:106634.(二区，IF=5.6 ) |
